市场调查报告书
商品编码
1363973
全球光声成像市场2023-2030Global Photoacoustic Imaging Market 2023-2030 |
预计全球光声成像市场在预测期内(2023-2030年)复合年增长率将达到10.9%。光声成像比纯光学成像具有更大的穿透力,比纯超音波成像具有更好的解析度。先进的生物组织诊断成像技术的日益普及是支持全球市场成长的关键因素。根据杜克大学的说法,光声成像对微小的光吸收变化具有 100.0% 的相对灵敏度,这意味着光吸收係数的给定百分比变化会产生 PA 讯号幅度的相同百分比变化。因此,市场参与者也专注于引入基于小光学吸收变化的光声成像解决方案,以进一步促进市场成长。例如,2021 年 4 月,Scintica Instrumentation Inc. 宣布与 TriTom 製造商 PhotoSound Technologies, Inc. 签订经销协议,TriTom 是一种基于光声萤光断层扫描 (PAFT) 的小动物全身活体成像系统。与生物医学光学和光声相关的技术的发展。
全球光声成像市场按产品、类型、应用和最终用户进行细分。根据产品,市场细分为成像系统、雷射和感测器。根据类型,市场分为断层扫描和显微镜。根据应用,市场细分为肿瘤学、心臟科、神经学、血液学等。此外,根据最终用户,市场细分为医院和诊断成像中心。在这些产品中,由于光声成像的发展,成像系统子细分市场预计将占据相当大的市场份额,光声成像是一种新兴的放射技术,透过测量光诱导的声音来产生组织的高清体积影像来自其光学吸收结构的波。
在这些应用中,肿瘤学细分市场预计将在全球光声成像市场中占据相当大的份额。分段增长归因于光声成像技术在癌症筛检中的日益增长的应用。光声成像是一种新兴的癌症分子成像方式,能够以前所未有的时空解析度以光学对比度对内源性组织髮色团进行非侵入性评估。各种新应用增强了体外诊断、影像引导治疗、体内诊断和创新癌症护理的基础。 2021 年 10 月,西门子 Healthineers 宣布首款光子计数电脑断层扫描仪 Naeotom Alpha 获得 FDA 510 (k) 批准。凭藉新颖的系统概念和开创性的新探测器技术,它开创了电脑断层扫描的新时代,这项技术决定了许多医疗决策的过程。这些发展进一步促进了该细分市场的成长。
全球光声成像市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本) 、韩国和亚洲其他地区)以及世界其他地区(中东和非洲以及拉丁美洲)。其中,由于北美地区的市场份额不断增加,预计北美将在全球市场中占据显着份额。癌症病例数量和医疗保健支出高。资金的增加促进了该地区的研究活动,进一步推动了该地区市场的成长。Advantest Corp. illumiSonics Inc.、PST Inc. 和Verasonics 等主要参与者的存在, Inc.正在进一步推动该区域市场的成长。
在所有地区中,亚太地区预计在预测期内将以相当大的复合年增长率成长。区域成长归因于该地区医疗器材製造公司的存在以及中国和印度等人口稠密国家购买力的成长。此外,癌症病例的增加推动了市场的成长。根据美国国立卫生研究院(NIH)统计,2022年6月,亚洲癌症发生率为每10万人169.1例,占全球癌症发生率的49.3%。最常见的癌症包括肺癌(13.8%)、乳癌(10.8%)和大肠癌(10.6%)。其死亡率为每10万人中101.6人(占全球癌症死亡的58.3%),其中肺癌(19.2%)、肝癌(10.5%)和胃癌(9.9%)是2020年癌症死亡的最常见原因。
对更好的成像设备的需求增加和研究活动频率的增加推动了市场的成长。例如,2021 年 9 月,韩国浦项科技大学 (POSTECH) 的一组研究人员开发了一种手持式光声探测器,可用于评估淋巴结状态,而无需使患者暴露在辐射下。主要市场参与者包括 PreXion、PST Inc.、Litron Lasers、FUJIFILM Visualsonics, Inc.、kibero、InnoLas Laser GmbH、BK Medical Holding Company, Inc.、EKSPLA、Aspectus GmbH、Advantest Corp. 和 Vibronix, Inc. 等。
Title: Global Photoacoustic Imaging Market Size, Share & Trends Analysis Report by Product (Imaging Systems, Lasers and Transducers), by Type (Tomography and Microscopy), by Application (Oncology, Cardiology, Neurology, Hematology and Others),and by End-Users(Hospitals and Diagnostic Imaging Centers),Forecast Period (2023-2030).
The global photoacoustic imaging market is anticipated to grow at a significant CAGR of 10.9% during the forecast period (2023-2030). Photoacoustic imaging offers greater penetration than pure optical imaging and better resolution than pure ultrasonic imaging. The growing adoption of advancing diagnostic imaging for biological tissues is the key factor supporting the growth of the market globally. According to Duke University, photoacoustic imaging has a 100.0% relative sensitivity to small optical absorption variations, that means a given percentage change in the optical absorption coefficient yields the same percentage change in the PA signal amplitude. Hence, the market players are also focusing on introducing small optical absorption variations based photoacoustic imaging solutions to further bolster the market growth. For instance, in April 2021, Scintica Instrumentation Inc. announced its distribution agreement with PhotoSound Technologies, Inc., manufacturer of the TriTom, a small animal whole body in vivo imaging system based on PhotoAcoustic Fluorescence Tomography (PAFT). The development of technologies associated with biomedical optics and photoacoustic.
The global photoacoustic imaging market is segmented on the product, type, application, and end-users. Based on the product, the market is sub-segmented into imaging systems, lasers and transducers. Based on the type, the market is sub-segmented into tomography and microscopy. Based on the application, the market is sub-segmented into oncology, cardiology, neurology, hematology and others. Further, on the basis of end users, the market is sub-segmented into hospitals and diagnostic imaging centers. Among the products, the imaging systems sub-segment is anticipated to hold a considerable share of the market owing to the rise in the development of optoacoustic imaging, an emerging radiological technology that generates high-definition volumetric images of tissue by measuring light-induced sound waves from its optically absorbing structures.
Among the applications, the oncology sub-segment is expected to hold a considerable share of the global photoacoustic imaging market. The segmental growth is attributed to the growing applications of the photoacoustic imaging technique in cancer screening. Photoacoustic imaging is an emerging modality for molecular imaging of cancer, enabling non-invasive assessment of endogenous tissue chromophores with optical contrast at unprecedented spatiotemporal resolution. Various new applications enhance the foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. In October 2021, Siemens Healthineers announced the FDA 510 (k) clearance of the Naeotom Alpha, the first photon-counting computer tomograph. With a novel system concept and pioneering new detector technology, it ushers in a new era in computed tomography, a technology that determines the course of many medical decisions. Such developments are further contributing to the growth of this market segment.
The global photoacoustic imaging market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the increasing number of cancer cases and high expenditure on healthcare. The improved funding has boosted the region's research activities which is further driving the growth of the regional market. The presence of key players such as Advantest Corp. illumiSonics Inc., PST Inc., and Verasonics, Inc. across the region is further driving the growth of the regional market.
Among all regions, the Asia-Pacific regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the presence of medical device manufacturing companies in the region as well as growth in the purchasing power of populated countries, such as China and India. Moreover, the rise in cancer cases drives the growth of the market. According to the National Institute of Health (NIH), in June 2022, the cancer incidence in Asia was 169.1 per 1 00 000, accounting for 49.3% of the global cancer incidence. The most common cancers included lung (13.8%), breast (10.8%) and colorectal (10.6%) cancers. Its mortality was 101.6 per 1 00 000 (58.3% of the global cancer death) with lung (19.2%), liver (10.5%) and stomach (9.9%) cancers being the most common causes of cancer death in 2020.
An increased demand for better imaging devices and the rising frequency of research activities drive market growth. For instance, in September 2021, a group of researchers from South Korea's Pohang University of Science and Technology (POSTECH) developed a handheld photoacoustic detector that can be used to assess lymph node status without exposing patients to radiation. The key market players include PreXion, PST Inc., Litron Lasers, FUJIFILM Visualsonics, Inc., kibero, InnoLas Laser GmbH, BK Medical Holding Company, Inc., EKSPLA, Aspectus GmbH, Advantest Corp., and Vibronix, Inc. and others.
The major companies serving the photoacoustic imaging market include FUJIFILM Holdings Corp., Advantest Corp., CYBERDYNE, Inc., Siemens Healthineers, PA Imagining R&D B.V. and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in October 2021, CYBERDYNE Inc. the Japan agency adopted the company's proposal on photoacoustic imaging technology For Medical Research and Development ("AMED") for its Medical and industrial collaboration innovation promotion project.